The above results of EM clustering in various subgroups suggest that in all three analyzed ER/PgR phenotypes, some patients had breast tumors that do not overexpress HER2 and have similar intermediate mitotic activity independent of the presence of ER and PgR (all IMA clusters). The gene discussed is PGR; the disease is breast neoplasm.